What is Human Longevity worth?
$250.0Mlast known valuation
Human Longevity last raised $32.0M in its Early Stage VC (Mar 2023).
Free account
See the evidence behind this price
- ·Post-money valuations for all 3 rounds
- ·The complete investor list — 36 names
- ·Watchlist + deal alerts for Human Longevity
Create free account
No card required
Funding history
3 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Mar 2023 | Early Stage VC | $32.0M | ▮ | ▮ |
| Sep 2021 | Early Stage VC | $6.9M | ▮ | ▮ |
| Jun 2019 | Early Stage VC | $20.1M | ▮ | ▮ |
How Human Longevity's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Human Longevity, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Human Longevity worth?
- Human Longevity's last known valuation is $250.0M.
- How much has Human Longevity raised?
- Human Longevity has raised $1.1B in total funding across 3 recorded rounds.
- When did Human Longevity last raise?
- Human Longevity last raised in Mar 2023 (Early Stage VC), raising $32.0M.